AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 19812581
Drug: Inhaled nitric
RxNorm normalized name: nitric oxide Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled nitric oxide (iNO) at 20 p.p.m. decreasing to 2 p.p.m. for 24 days
Trial: 11915394
Drug: Standard injections
RxNorm normalized name: Stangard
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Standard injections
Trial: 10396711
Drug: Ketamine 50
RxNorm normalized name: ketamine 50 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine 50 mg
Trial: 10396711
Drug: Ketamine 100
RxNorm normalized name: ketamine 100 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine 100 mg
Trial: 10396711
Drug: Ketamine 150
RxNorm normalized name: bupivacaine/ketorolac/ketamine 150 mg-60 mg-60 mg/50 mL INJECTION SYRINGE (ML)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine 150 mg
Trial: 10396711
Drug: Ketamine 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine 200 mg
Trial: 7484046
Drug: 30 ml
RxNorm normalized name: Vial M/T 30 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 ml of 1% prilocaine plus 6 mg morphine sulfate in 10 ml of 0.9% sodium chloride (P/M group)
Trial: 7484046
Drug: 30 ml
RxNorm normalized name: Vial M/T 30 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 ml of 1% prilocaine plus 10 ml of 0.9% sodium chloride (P group)
Trial: 2292535
Drug: Comparative antibiotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparative antibiotics
Trial: 26059872
Drug: Home visits
RxNorm normalized name: benzalkonium
DrugBank: Benzalkonium (DB11105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Home visits with a general practitioner and municipal nurse within seven days of discharge focusing on medication, rehabilitation plan, functional level, and need for further health care initiatives.
Trial: 23463656
Drug: GLP-1 infusion
RxNorm normalized name: Arg34Lys26-(N-ε-(γ-Glu(N-α-hexadecanoyl)))-GLP-1[7-37]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GLP-1 infusion for 2 hours
Trial: 21483704
Drug: Internet-based cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Internet-based cognitive behavior therapy (ICBT), n=64
Trial: 21483704
Drug: Cognitive behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive behavioral group therapy (CBGT), n=62
Trial: 17228550
Drug: Treatment with
RxNorm normalized name: Campho-Phenique Cold Sore Treatment with Drying Action
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment with antidepressants
Trial: 9007493
Drug: 50 IU
RxNorm normalized name: Pegaspargase 750 IU/1 ML Injection Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 IU r‐HuEpo/kg, subcutaneously thrice weekly
Trial: 9007493
Drug: 100 IU
RxNorm normalized name: Vitamin E 100 IU Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 IU r‐HuEpo/kg, subcutaneously thrice weekly
Trial: 29152749
Drug: Topical nasal
RxNorm normalized name: Nasal Inhalant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical nasal anesthetic (0.4 mL of 2% viscous lidocaine hydrochloride)
Trial: 29152749
Drug: Topical nasal
RxNorm normalized name: Nasal Inhalant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical nasal anesthetic
Trial: 27503659
Drug: 250 mg
RxNorm normalized name: rutin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg REL plus 500 mg IMI
Trial: 27503659
Drug: 125 mg
RxNorm normalized name: niacin 125 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 125 mg REL plus 500 mg IMI
Trial: 27503659
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg IMI alone
Trial: 20133012
Drug: Imiquimod 2.5%
RxNorm normalized name: IMIQUIMOD 2.5% CREAM,TOP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imiquimod 2.5% cream
Trial: 20133012
Drug: Imiquimod 3.75%
RxNorm normalized name: IMIQUIMOD 3.75% CREAM,TOP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imiquimod 3.75% cream
Trial: 14625812
Drug: Interferon alpha
RxNorm normalized name: Interferon alpha-2a
DrugBank: Interferon alfa-2a (DB00034)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon alpha 2b (3 x 3 MIU sc weekly) and oral ribavirin (1000/1200 mg po daily) for 24 weeks
Trial: 14625812
Drug: Interferon alpha
RxNorm normalized name: Interferon alpha-2a
DrugBank: Interferon alfa-2a (DB00034)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon alpha 2b (3 x 3 MIU sc weekly) and oral ribavirin (1000/1200 mg po daily) for 48 weeks
Trial: 8690831
Drug: ICI 204,636
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ICI 204,636 (75 to 750 mg daily)
Trial: 264798
Drug: Cranial irradiation
RxNorm normalized name: geranial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cranial irradiation combined with a 3-year course of multiple drug systemic chemotherapy
Trial: 264798
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose palliative irradiation
Trial: 264798
Drug: Multiple agent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple agent chemotherapy and preventive meningeal irradiation
Trial: 27298379
Drug: Carvedilol (12±1.67
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carvedilol (12±1.67 mg/day)
Trial: 22094037
Drug: Ephedrine (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ephedrine (4 g/L)
Trial: 22094037
Drug: Ephedrine plus
RxNorm normalized name: EPHEDRINE HYDROCHLORIDE 12.5 mg / GUAIFENESIN 200 mg ORAL TABLET [Red Label Ephedrine Plus]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ephedrine plus Phenylephrine (ephedrine 2 g/L + phenylephrine 25 mg/L)
Trial: 22094037
Drug: Phenylephrine (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenylephrine (50 mg/L)
Trial: 12779280
Drug: Lidocaine cream
RxNorm normalized name: Neomycin and Polymyxin B Sulfates and Lidocaine Cream
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lidocaine cream (6%)
Trial: 12779280
Drug: Tetracaine cream
RxNorm normalized name: BENZALKONIUM CL/BENZOCAINE/DIBUCAINE/TETRACAINE CREAM,TOP
DrugBank: Tetracaine (DB09085)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tetracaine cream (4%)
Trial: 10684018
Drug: 0.82 g.kg‐1.d‐1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.82 g.kg‐1.d‐1 fat emulsion (42% of total calorie)
Trial: 10684018
Drug: 1.72 g.kg‐1.d‐1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.72 g.kg‐1.d‐1 fat emulsion (52% of total calorie)
Trial: 322634
Drug: Affect-arousing, gestalt
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Affect-arousing, gestalt therapy
Trial: 29775202
Drug: Aspirin 100
RxNorm normalized name: aspirin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin 100 μM with 0.05% DMSO
Trial: 29775202
Drug: 0.05% DMSO
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.05% DMSO without aspirin
Trial: 26024743
Drug: Lipegfilgrastim 6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lipegfilgrastim 6 mg once per cycle
Trial: 26024743
Drug: Pegfilgrastim 6
RxNorm normalized name: PEGFILGRASTIM 6MG/0.6ML DELIVERY KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pegfilgrastim 6 mg once per cycle
Trial: 20105189
Drug: rs4410646 genotype
RxNorm normalized name: PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 8
DrugBank: Streptococcus pneumoniae type 8 capsular polysaccharide antigen (DB10326)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rs4410646 genotype (CC)
Trial: 10570387
Drug: 1.8% tetracaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.8% tetracaine cream
Trial: 1816827
Drug: Collective measures
RxNorm normalized name: MEASLES VIRUS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Collective measures of oral hygiene (monthly, quarterly, half-yearly intervals)
Trial: 1816827
Drug: Twice instructed
RxNorm normalized name: Tice BCG
DrugBank: Bacillus calmette-guerin substrain tice live antigen (DB10343)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twice instructed measures of oral hygiene
Trial: 7280450
Drug: Octavalent vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Octavalent vaccine (Eli Lilly Laboratories) given at six months and/or 12 months of age
Trial: 7280450
Drug: 14-valent vaccine
RxNorm normalized name: L1 protein, human papillomavirus type 31 vaccine
DrugBank: Human papillomavirus type 31 L1 capsid protein antigen (DB10310)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 14-valent vaccine (Merck Sharp & Dohme) given at 12 months of age
Trial: 30712247
Drug: Warfarin dosing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin dosing based on genetic testing
Trial: 27363396
Drug: Shakuyaku‐kanzo‐to (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shakuyaku‐kanzo‐to (2.5 g as needed)
Trial: 27363396
Drug: Shakuyaku‐kanzo‐to (7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shakuyaku‐kanzo‐to (7.5 g/day)
Trial: 7681516
Drug: Oral dofetilide
RxNorm normalized name: Dofetilide
DrugBank: Dofetilide (DB00204)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral dofetilide (5 micrograms/kg)
Trial: 7681516
Drug: Oral dofetilide
RxNorm normalized name: Dofetilide
DrugBank: Dofetilide (DB00204)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral dofetilide (7.5 micrograms/kg)
Trial: 7681516
Drug: Oral dofetilide
RxNorm normalized name: Dofetilide
DrugBank: Dofetilide (DB00204)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral dofetilide (10 micrograms/kg)
Trial: 7681516
Drug: Intravenous dofetilide
RxNorm normalized name: Dofetilide
DrugBank: Dofetilide (DB00204)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous dofetilide (0.5 mg)
Trial: 7681516
Drug: Oral dofetilide
RxNorm normalized name: Dofetilide
DrugBank: Dofetilide (DB00204)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral dofetilide (0.5 mg)
Trial: 2877594
Drug: NaCl 0.9%
RxNorm normalized name: DEXTROSE 5%/NACL 0.9% INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NaCl 0.9% and 0.1 mg fentanyl (control group C)
Trial: 28197979
Drug: OM3-CA 4
RxNorm normalized name: Ca 2+
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OM3-CA 4 g
Trial: 27686403
Drug: 2% CAF
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2% CAF solution
Trial: 22969732
Drug: Modafinil 200
RxNorm normalized name: modafinil 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modafinil 200 mg plus d-amphetamine 30 mg
Trial: 22969732
Drug: d-amphetamine 60
RxNorm normalized name: amphetamine / dextroamphetamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: d-amphetamine 60 mg
Trial: 19112722
Drug: Acetylsalicylic acid
RxNorm normalized name: ACETYLSALICYLIC ACID
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acetylsalicylic acid 500 mg per day
Trial: 19112722
Drug: Ibuprofen 400
RxNorm normalized name: ibuprofen 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen 400 mg per day
Trial: 19112722
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups (Acetylsalicylic acid and Ibuprofen)
Trial: 10209373
Drug: Prilocaine 3%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prilocaine 3% with felypressin 0.03 IU.ml‐1
Trial: 25311998
Drug: Combination Intervention
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination Intervention Strategy (CIS) including point-of-care CD4 count testing, accelerated antiretroviral therapy initiation, SMS reminders for linkage and retention in care
Trial: 25311998
Drug: Combination Intervention
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination Intervention Strategy plus Financial Incentives (CIS + FI)
Trial: 20837352
Drug: 10 g
RxNorm normalized name: Co Q-10 Gummies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 g of test oil containing 27.3% DAG
Trial: 20837352
Drug: 10 g
RxNorm normalized name: Co Q-10 Gummies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 g of test oil containing 54.6% DAG
Trial: 16325031
Drug: Imatinib (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imatinib (600 mg/day for 10 days starting 2 days before repeat intervention)
Trial: 7906539
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment (Apraclonidine 1% and Pilocarpine 4%)
Trial: 2780105
Drug: Minocycline 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Minocycline 200 mg/24 h for 7 days plus saline irrigation of the operative site.
Trial: 2780105
Drug: Cefotiam (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefotiam (2 g intraoperatively, 2 g at 12 hours and 24 hours post-surgery) plus Povidone iodine (5% dilution) irrigation of the operative site.
Trial: 1219635
Drug: Acebutolol (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acebutolol (600 to 800 mg)
Trial: 29871185
Drug: Intratympanic injection
RxNorm normalized name: ciprofloxacin
DrugBank: Ciprofloxacin (DB00537)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intratympanic injection with mouse nerve growth factor and methylprednisolone
Trial: 29871185
Drug: Conventional medication
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional medication and methylprednisolone (0.5 ml) + 0.9% NaCl (0.5 ml)
Trial: 24589090
Drug: Immunonutrition (oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immunonutrition (oral supplementation containing arginine, ω‐3 fatty acids, and RNA for 5 days before surgery)
Trial: 15655825
Drug: HCC vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HCC vaccine group
Trial: 7535669
Drug: Pirenzepine (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pirenzepine (200 mg orally)
Trial: 7535669
Drug: GH releasing
RxNorm normalized name: FUSION PROTEIN OF HUMAN CHORIOGONADOTROPIN SUBUNIT .BETA. (CG- .BETA.)-(118-145)-PEPTIDE (1-28) WITH HUMAN SOMATOTROPIN (GROWTH HORMONE, GH) (29-219) AND TWO TANDEM COPIES OF HUMAN CHORIOGONADOTROPIN SUBUNIT .BETA. (CG-.BETA.)-(118-145)- PEPTIDE (220-247
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GH releasing hormone (GHRH) 1‐44 (80 micrograms i.v.)
Trial: 15894
Drug: Intramuscular injection
RxNorm normalized name: rabies, intramuscular injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular injection of 50 mg progesterone and 3 mg oestradiol benzoate in oil
Trial: 15894
Drug: No hormonal
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: No hormonal injection (Control)
Trial: 29428088
Drug: Parenteral cobalamin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parenteral cobalamin (0.4–1.2 mg hydroxycobalamin according to body weight)
Trial: 29428088
Drug: Oral cobalamin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral cobalamin tablets (0.25–1.0 mg cyanocobalamin daily according to body weight)
Trial: 24980426
Drug: Gabapentin 600
RxNorm normalized name: gabapentin 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabapentin 600 mg before surgery followed by 200 mg TID for 4 days
Trial: 18473407
Drug: 7-day therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7-day therapy (omeprazole 20 mg bid, clarithromycin 500 mg bid, amoxicillin 1 g bid)
Trial: 18473407
Drug: 10-day therapy
RxNorm normalized name: tetracycline
DrugBank: Tetracycline (DB00759)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 10-day therapy (same medication as group 1)
Trial: 18473407
Drug: 7-day therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7-day therapy
Trial: 18473407
Drug: 10-day therapy
RxNorm normalized name: tetracycline
DrugBank: Tetracycline (DB00759)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 10-day therapy
Trial: 12809972
Drug: Increased copayments
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Increased copayments in 1995 and 1997 for antidepressants, anxiolytics, and sedatives
Trial: 12809972
Drug: Increased copayments
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Increased copayments in 1997 for antidepressants
Trial: 1407968
Drug: Aspirin 650
RxNorm normalized name: aspirin 650 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin 650 mg/day
Trial: 2860268
Drug: Piretanide 12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piretanide 12 mg daily (n = 14)
Trial: 2860268
Drug: Piretanide 6
RxNorm normalized name: piretanide 6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piretanide 6 mg daily (n = 18)
Trial: 2860268
Drug: Beta blockers
RxNorm normalized name: BETA BLOCKERS/RELATED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta blockers (pindolol, metipranolol, atenolol, n = 17)
Trial: 27514766
Drug: Omega-3 fatty
RxNorm normalized name: Omega-3 fatty acid
DrugBank: Omega-3 fatty acids (DB11133)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omega-3 fatty acid supplementation (1000 mg/d from flaxseed oil)
Trial: 25522399
Drug: Lithium treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lithium treatment (6 weeks)
Trial: 19855976
Drug: Sildenafil citrate
RxNorm normalized name: Sildenafil Citrate
DrugBank: Sildenafil (DB00203)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sildenafil citrate only (25 mg, four times/week)
Trial: 19855976
Drug: Tamsulosin only
RxNorm normalized name: Tamsulosin only product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamsulosin only (0.4 mg once daily)
Trial: 19855976
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of sildenafil citrate and tamsulosin
Trial: 18721577
Drug: iNO +
RxNorm normalized name: INO
DrugBank: Inosine (DB04335)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: iNO + Mil (inhalation of nitric oxide plus milrinone)
Trial: 18721577
Drug: iNO (inhalation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: iNO (inhalation of nitric oxide)
Trial: 12464165
Drug: Oral immunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral immunotherapy with Alternaria extract (mean accumulated dose: 280,000 PNU)
Trial: 12464165
Drug: Oral immunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral immunotherapy with Alternaria extract
Trial: 1868680
Drug: Low-dose phenobarbital
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose phenobarbital incorporated into methadone medication
Trial: 28138179
Drug: Thiopental 3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiopental 3 mg/kg intravenously followed by an additional dose of 1 mg/kg to achieve Ramsay sedation score of 4
Trial: 28138179
Drug: Ketofol (1:1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketofol (1:1 mixture of ketamine 10 mg/mL and propofol 10 mg/mL) at a dose of 0.5 mg/kg at 1 minute intervals to achieve Ramsay sedation score of 4
Trial: 25349008
Drug: Morphine (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine (0.5 mg/kg orally)
Trial: 21797891
Drug: Intravenous alcohol
RxNorm normalized name: Alcohol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous alcohol infusion (50 mg%) for 3 hours
Trial: 21797891
Drug: Saline infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline infusion for 3 hours
Trial: 15827099
Drug: octreotide-LAR (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: octreotide-LAR (10 mg, n = 10 subjects)
Trial: 12072674
Drug: Intravenous erythromycin
RxNorm normalized name: Erythromycin
DrugBank: Erythromycin (DB00199)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous erythromycin (250 mg/6 hrs)
Trial: 12072674
Drug: Placebo (intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (intravenous 5% dextrose, 50 mL/6 hrs)
Trial: 1325513
Drug: Spirapril (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spirapril (both doses)
Trial: 30556959
Drug: Miridesap 10
RxNorm normalized name: Miridesap
DrugBank: Miridesap (DB13087)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Miridesap 10 mg IV infusion
Trial: 30556959
Drug: Miridesap 20
RxNorm normalized name: Miridesap
DrugBank: Miridesap (DB13087)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Miridesap 20 mg IV infusion
Trial: 30556959
Drug: Miridesap 40
RxNorm normalized name: Miridesap
DrugBank: Miridesap (DB13087)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Miridesap 40 mg IV infusion
Trial: 30556959
Drug: Miridesap 20
RxNorm normalized name: Miridesap
DrugBank: Miridesap (DB13087)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Miridesap 20 mg/h IV infusion (15-hour duration)
Trial: 28926864
Drug: Conductive Mitomycin
RxNorm normalized name: Mitomycin
DrugBank: Mitomycin (DB00305)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conductive Mitomycin C therapy (Combat ® and Unithermia ® devices)
Trial: 26708124
Drug: Fluoxetine (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine (8 to 15 mg, titrated to weight)
Trial: 24644106
Drug: Duloxetine 30-120
RxNorm normalized name: duloxetine 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duloxetine 30-120 mg once daily
Trial: 9237705
Drug: Adefovir dipivoxil
RxNorm normalized name: Adefovir Dipivoxil
DrugBank: Adefovir dipivoxil (DB00718)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Adefovir dipivoxil (125 mg, 250 mg, 500 mg daily for 14 days)
Trial: 9237705
Drug: Adefovir dipivoxil
RxNorm normalized name: Adefovir Dipivoxil
DrugBank: Adefovir dipivoxil (DB00718)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Adefovir dipivoxil (125 mg daily)
Trial: 2448657
Drug: High-dose methotrexate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose methotrexate (3 g/m2 iv weekly with leukovorin rescue)
Trial: 2448657
Drug: Low-dose methotrexate
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose methotrexate (30 mg/m2 orally weekly without rescue)